Neuronal death in nigral grafts in the absence of poly (ADP-ribose) polymerase activation

NeuroReport

Volumn 10, Issue 16, 1999, Pages 3347-3351

  Kaminski Schierle, Gabriele S ^a   Hansson, Oskar ^a   Ferrando May, Elisa ^b   Nicotera, Pierluigi ^b   Brundin, Patrik ^a   Leist, Marcel ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Apoptosis; Dopamine; Necrosis; Neural transplantation; Parkinson's disease; PARP; Substantia nigra

Indexed keywords

CASPASE; DNA FRAGMENT; LACTATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL LOSS; CELL PROTECTION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME RELEASE; GENE DELETION; GRAFT SURVIVAL; KNOCKOUT MOUSE; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

EID: 0032693326     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199911080-00017     Document Type: Article

References (24)

1. 1. Lindvall O. Neuroreport 8, iii-x (1997).
2. 2. Tabbal S, Fahn S and Frucht S. Curr Opin Neurol 11, 341-349 (1998).
3. 3. Brundin P and Kaminski Schierle GS. Neuroprotective strategies in neural grafting. In: Dunnett SB, Boulton AA and Baker GB, eds. Neural Transplantation Methods. Totowa, NJ: Humana Press Inc, 1999. 411-440.
4. 4. Widner H and Brundin P. Exp Brain Res 104, 227-242 (1995).
5. 5. Schierle GS, Hansson O, Leist M et al. Nature Med 5, 97-100 (1999).
6. 6. Zawada WM, Zastrow DJ, Clarkson ED et al. Brain Res 786, 96-103 (1998).
7. 7. de Murcia G and Ménissier de Murcia J. Trends Biochem Sci 19, 172-176 (1994).
8. 8. Lazebnik YA, Kaufmann SH, Desnoyers S et al. Nature 371, 346-347 (1994).
9. 9. Leist M, Single B, Kunstle G et al. Biochem Biophys Res Commun 334, 518-522 (1997).
10. 10. Wang Z-Q, Stingl L, Morrison C et al. Genes Dev 11 2347-2358 (1997).
11. 11. Szabo C and Dawson VL. Trends Pharmacol Sci 19, 287-298 (1998).
12. 12. Pieper AA, Verma A, Zhang J and Snyder SH. Trends Pharmacol Sci 20, 171-181 (1999).
13. 13. de Murcia JM, Niedergang C, Trucco C et al. Proc Natl Acad Sci USA 94, 7303-7307(1997).
14. 14. Wang Z-Q, Auer B, Stingl L et al. Genes Dev 9, 509-520 (1995).
15. 15. Eliasson MJL, Sampei K, Mandir AS et al. Nature Med 3, 1089-1095 (1997).
16. 16. Endres M, Wang ZQ, Namura S et al. J Cerebr Blood Flow Metab 17, 1143-1153 (1997).
17. 17. Mandir AS, Przedborski S, Jackson-Lewis V et al. Proc Natl Acad Sci USA 96, 5774-5779 (1999).
18. 18. Karlsson J, Emgard M, Rosenblad C, Brundin P. Brain Res 805, 155-168 (1998).
19. 19. Schierle GS, Leist M, Martinou JC et al. Eur J Neurosci 11, 3073-3081 (1999).
20. 20. Leist M, Volbracht C, Kuhnle S et al. Mol Med 3, 750-764 (1997).
21. 21. Brundin P, Nilsson OG, Gage FH and Bjorklund A. Exp Brain Res 60, 204-208 (1985).
22. 22. West MJ, Slomianka L and Gundersen HJ. Anat Rec 231, 482-497 (1991).
23. 23. Nicotera P, Leist M and Manzo L. Trends Pharmacol Sci 20, 46-51 (1999).
24. 24. Van Muiswinkel FL, Drukarch B, Steinbusch MW and De Vente J. Brain Res 792, 48-58 (1998).